✦ LIBER ✦
O.105 Early clinical results with CPG 10101, a new investigational antiviral TRL9 agonist being developed for treatment of subjects chronically infected with hepatitis C virus
✍ Scribed by J.G. McHutchison; B.R. Bacon; S.C. Gordon; E. Lawitz; M. Shiffman; N.H. Afdhal; I.M. Jacobson; A. Muir; R. Ghalib; P. Kwo; B. Freilich; H.L. Davis; A. Vicari; S. Efler; M. Al-Adhami; M.L. Morris; F. Masciari; J.L. Himes
- Book ID
- 117770142
- Publisher
- Elsevier Science
- Year
- 2006
- Tongue
- English
- Weight
- 132 KB
- Volume
- 36
- Category
- Article
- ISSN
- 1386-6532
No coin nor oath required. For personal study only.